SCHEMBL32688278

SCHEMBL32688278

N#Cc1c(-c2cccc(C(=O)Nc3ccccc3)c2)nc(SCc2nnn[nH]2)[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 6/20 0.57
▸ POLB P06746 6/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ CXCR2 P25025 2/20 0.52
▸ BRD4 O60885 1/20 0.50
▸ HSD11B1 P28845 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ LDHA P00338 2/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ LDHB P07195 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ TNF P01375 2/20 0.48
▸ NOD2 Q9HC29 2/20 0.48
▸ NOD1 Q9Y239 2/20 0.48
▸ PLA2G1B P04054 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688478 0.85 ALDH1A1 (0.41) ACMSDPOLBMEN1KMT2ACXCR2
SCHEMBL32688271 0.83 ALDH1A1 (0.42) ACMSDPOLBMEN1KMT2ALMNA
SCHEMBL32688374 0.82 NPC1 (0.40) ACMSDPOLBMEN1KMT2ACXCR2
SCHEMBL32688409 0.78 ACMSD (0.49) ACMSDPOLBMEN1KMT2ALMNA
SCHEMBL32688238 0.77 PTPN1 (0.39) ACMSDMEN1KMT2AHSD11B1LMNA
SCHEMBL32688221 0.76 SIRT2 (0.46) POLBMEN1KMT2AMAPTRXFP1
SCHEMBL29272645 0.76 BRD4 (0.70) ACMSDPOLBMEN1KMT2ACXCR2
SCHEMBL29554992 0.76 BRD4 (0.70) ACMSDPOLBMEN1KMT2ACXCR2
SCHEMBL32688056 0.76 MET (0.41) POLBMEN1KMT2ALMNAMAPT
SCHEMBL32688358 0.75 PSMD14 (0.43) POLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ACMSD 142/4885POLB 508/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback